SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 214.64 |
| Enterprise Value ($M) | 354.47 |
| Book Value ($M) | 148.91 |
| Book Value / Share | 7.03 |
| Price / Book | 1.44 |
| NCAV ($M) | 36.68 |
| NCAV / Share | 1.73 |
| Price / NCAV | 5.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.92 |
| Current Ratio | 4.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 286.58 |
| Assets | 398.82 |
| Liabilities | 249.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.72 | -51.55 | |
| 13G/A | Millennium Management Llc | 3.50 | -44.39 | |
| 13G/A | Vanguard Group Inc | 8.52 | 17.84 | |
| 13G/A | Farallon Capital Partners, L.P. | 9.60 | 30.65 | |
| 13G/A | BlackRock, Inc. | 9.20 | -2.19 | |
| 13G/A | State Street Corp | 2.02 | -71.85 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 40,011 | 144,537 | 27.68 | |
| 13,019 | 69,562 | 18.72 | |
| 22,233 | 103,465 | 21.49 | |
| 18,863 | 108,004 | 17.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EDIT – Editas Medicine, Inc. | ELEV – Elevation Oncology, Inc. |
| ELVN – Enliven Therapeutics, Inc. | ERAS – Erasca, Inc. |
| EWTX – Edgewise Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io